News of the WeekClinical Trials

Gene Therapy Death Prompts Review of Adenovirus Vector

See allHide authors and affiliations

Science  17 Dec 1999:
Vol. 286, Issue 5448, pp. 2244-2245
DOI: 10.1126/science.286.5448.2244

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

For the past 3 months, faculty and staff members at the University of Pennsylvania's Institute for Human Gene Therapy have been trying to understand why a relatively fit 18-year-old with an inherited enzyme deficiency died on 17 September, 4 days after doctors at Penn injected a genetically altered virus into his liver. Last week, they presented their data to a government advisory committee. The patient was the first in a gene therapy trial to die of the therapy itself; his death is the latest blow to a field that has been struggling to live up to the promise and hype surrounding the first gene therapy trials a decade ago.